SIV vaccineAlternative Names: SIVdelta3
Latest Information Update: 16 Oct 2007
At a glance
- Originator Endocon; Institut Pasteur
- Developer Chiron Corporation; Endocon; Harvard Medical School; National Institutes of Health (USA); New England Regional Primate Center; Nonindustrial source; TSI Mason Laboratories; University of California, Davis
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV infections